Financhill
Back

Rhythm Pharmaceuticals Quote, Financials, Valuation and Earnings

America's Final Republican President

Click here to see his 2024 election prediction.
Buy
56

RYTM
Rhythm Pharmaceuticals

Last Price:
39.79
Seasonality Move:
13.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Stock Market Legend Shares Biggest Prediction Ever:

Click Here to See

Rhythm Pharmaceuticals Price Quote

$39.79
-0.01 (2.5%)
(Updated: May 1, 2024 at 6:17 AM ET)

Rhythm Pharmaceuticals Key Stats

Buy
56
Rhythm Pharmaceuticals (RYTM) is a Buy

Day range:
$37.60 - $41.27
52-week range:
$15.50 - $52.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
29.64
P/B ratio:
14.3%

Volume:
503.1K
Avg. volume:
519.4K
1-year change:
97.32%
Market cap:
$2.4B
Revenue:
$77.4M
EPS:
$-3.2

How Much Does Rhythm Pharmaceuticals Make?

Is Rhythm Pharmaceuticals Growing As A Company?

Rhythm Pharmaceuticals Stock Price Performance

What Is Rhythm Pharmaceuticals 52-Week High & Low?

Rhythm Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Rhythm Pharmaceuticals?

Is Rhythm Pharmaceuticals Cash Flow Positive?

  • What Is RYTM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$136.2M
  • What Is Rhythm Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $74.4M
  • What Is Rhythm Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$5.7M

Rhythm Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    RYTM return on invested capital is -89.34%
  • What Is Rhythm Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -53.53%
  • What Is RYTM Return On Equity?
    ROE is a measure of profitability and is -89.34%

Rhythm Pharmaceuticals Earnings Date & Stock Price

Rhythm Pharmaceuticals Competitors

Rhythm Pharmaceuticals Dividend Yield

Data Unavailable

Rhythm Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0.94%
Revenue: 175.7% -4.52%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 57.33
Upside from Last Price: 44.05%

Major Shareholders

  • How many RYTM shares are owned by institutional investors?
    111.7M RYTM shares are owned by institutional investors
  • How many RYTM shares are owned by insiders?
    1.1M RYTM shares are owned by insiders